Shares of Sabra Healthcare REIT Inc. (NASDAQ:SBRA) traded down 3.6% on Monday . The company traded as low as $22.62 and last traded at $23.30, with a volume of 597,925 shares trading hands. The stock had previously closed at $24.17.

A number of analysts have weighed in on the company. Canaccord Genuity reiterated a “hold” rating on shares of Sabra Healthcare REIT in a research report on Monday, May 2nd. SunTrust Banks Inc. raised Sabra Healthcare REIT from a “neutral” rating to a “buy” rating and set a $25.00 price objective on the stock in a research note on Wednesday, June 1st. Zacks Investment Research raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research note on Tuesday, July 5th. Bank of America Corp. lowered Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating in a research note on Monday. Finally, Cantor Fitzgerald initiated coverage on Sabra Healthcare REIT in a research note on Thursday, June 23rd. They issued a “buy” rating and a $28.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company’s stock. Sabra Healthcare REIT presently has a consensus rating of “Hold” and a consensus target price of $23.04.

The company has a market cap of $1.55 billion and a PE ratio of 44.47. The firm’s 50-day moving average is $21.58 and its 200-day moving average is $20.24.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, May 2nd. The company reported $0.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by $0.02. The business earned $62.60 million during the quarter, compared to analysts’ expectations of $57.50 million. Sabra Healthcare REIT’s quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.53 EPS. On average, equities research analysts expect that Sabra Healthcare REIT Inc. will post $2.25 EPS for the current fiscal year.

In related news, Director Milton J. Walters sold 2,000 shares of the stock in a transaction on Monday, June 6th. The stock was sold at an average price of $22.04, for a total value of $44,080.00. Following the sale, the director now owns 24,055 shares in the company, valued at $530,172.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Several large investors have modified their holdings of the company. Morgan Stanley increased its stake in shares of Sabra Healthcare REIT by 0.9% in the fourth quarter. Morgan Stanley now owns 55,899 shares of the company’s stock worth $1,131,000 after buying an additional 495 shares during the period. New York State Common Retirement Fund increased its stake in shares of Sabra Healthcare REIT by 4.7% in the fourth quarter. New York State Common Retirement Fund now owns 82,967 shares of the company’s stock worth $1,678,000 after buying an additional 3,703 shares during the period. Rhumbline Advisers increased its stake in shares of Sabra Healthcare REIT by 4.7% in the fourth quarter. Rhumbline Advisers now owns 102,430 shares of the company’s stock worth $2,072,000 after buying an additional 4,565 shares during the period. California Public Employees Retirement System increased its stake in shares of Sabra Healthcare REIT by 1.3% in the fourth quarter. California Public Employees Retirement System now owns 109,400 shares of the company’s stock worth $2,213,000 after buying an additional 1,400 shares during the period. Finally, California State Teachers Retirement System increased its stake in shares of Sabra Healthcare REIT by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 120,686 shares of the company’s stock worth $2,441,000 after buying an additional 1,903 shares during the period.

Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.